Generation bio to present at the canaccord genuity 43rd annual growth conference

Cambridge, mass., aug. 03, 2023 (globe newswire) -- generation bio co. (nasdaq:gbio), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that matt norkunas, m.d., chief financial officer, will present at the 2023 canaccord healthcare conference on thursday, august 10, 2023 at 11:00 a.m. et in boston.

GBIO Ratings Summary

GBIO Quant Ranking